Bank of America’s Wave Life Sciences WVE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.72M | Buy |
236,760
+53,905
| +29% | +$702K | ﹤0.01% | 4213 |
|
|
2025
Q4 | $3.11M | Sell |
182,855
-482,295
| -73% | -$4.9M | ﹤0.01% | 3726 |
|
|
2025
Q3 | $4.87M | Buy |
665,150
+19,590
| +3% | +$158K | ﹤0.01% | 4044 |
|
|
2025
Q2 | $4.2M | Buy |
645,560
+110,295
| +21% | +$728K | ﹤0.01% | 4077 |
|
|
2025
Q1 | $4.32M | Buy |
535,265
+99,369
| +23% | +$1.09M | ﹤0.01% | 3962 |
|
|
2024
Q4 | $5.39M | Buy |
435,896
+160,820
| +58% | +$2.15M | ﹤0.01% | 3523 |
|
|
2024
Q3 | $2.26M | Buy |
275,076
+200,003
| +266% | +$1.2M | ﹤0.01% | 4464 |
|
|
2024
Q2 | $375K | Sell |
75,073
-18,413
| -20% | -$105K | ﹤0.01% | 5523 |
|
|
2024
Q1 | $577K | Buy |
93,486
+31,260
| +50% | +$157K | ﹤0.01% | 5270 |
|
|
2023
Q4 | $314K | Buy |
62,226
+17,247
| +38% | +$92.2K | ﹤0.01% | 5806 |
|
|
2023
Q3 | $259K | Sell |
44,979
-11,683
| -21% | -$53.3K | ﹤0.01% | 5743 |
|
|
2023
Q2 | $206K | Sell |
56,662
-518,716
| -90% | -$2.1M | ﹤0.01% | 5806 |
|
|
2023
Q1 | $2.49M | Buy |
575,378
+510,320
| +784% | +$2.34M | ﹤0.01% | 4164 |
|
|
2022
Q4 | $455K | Buy |
65,058
+34,593
| +114% | +$159K | ﹤0.01% | 5452 |
|
|
2022
Q3 | $110K | Buy |
30,465
+9,228
| +43% | +$30.6K | ﹤0.01% | 6302 |
|
|
2022
Q2 | $69K | Buy |
21,237
+9,309
| +78% | +$17.9K | ﹤0.01% | 6672 |
|
|
2022
Q1 | $24K | Sell |
11,928
-11,066
| -48% | -$27.1K | ﹤0.01% | 7456 |
|
|
2021
Q4 | $73K | Buy |
22,994
+2,498
| +12% | +$10.4K | ﹤0.01% | 7031 |
|
|
2021
Q3 | $100K | Buy |
20,496
+3,430
| +20% | +$20.8K | ﹤0.01% | 6728 |
|
|
2021
Q2 | $114K | Sell |
17,066
-30,861
| -64% | -$202K | ﹤0.01% | 6446 |
|
|
2021
Q1 | $268K | Buy |
47,927
+30,484
| +175% | +$293K | ﹤0.01% | 5823 |
|
|
2020
Q4 | $137K | Buy |
17,443
+3,291
| +23% | +$27.6K | ﹤0.01% | 5828 |
|
|
2020
Q3 | $120K | Sell |
14,152
-344
| -2% | -$3.77K | ﹤0.01% | 5590 |
|
|
2020
Q2 | $151K | Sell |
14,496
-11,473
| -44% | -$108K | ﹤0.01% | 5436 |
|
|
2020
Q1 | $244K | Buy |
25,969
+14,919
| +135% | +$127K | ﹤0.01% | 4975 |
|
|
2019
Q4 | $89K | Sell |
11,050
-4,078
| -27% | -$100K | ﹤0.01% | 6041 |
|
|
2019
Q3 | $311K | Sell |
15,128
-17,182
| -53% | -$394K | ﹤0.01% | 5394 |
|
|
2019
Q2 | $843K | Buy |
32,310
+4,682
| +17% | +$131K | ﹤0.01% | 4692 |
|
|
2019
Q1 | $1.07M | Buy |
27,628
+16,362
| +145% | +$664K | ﹤0.01% | 4466 |
|
|
2018
Q4 | $473K | Buy |
11,266
+7,746
| +220% | +$344K | ﹤0.01% | 4975 |
|
|
2018
Q3 | $176K | Buy |
3,520
+689
| +24% | +$31.1K | ﹤0.01% | 5552 |
|
|
2018
Q2 | $108K | Sell |
2,831
-5,010
| -64% | -$216K | ﹤0.01% | 5759 |
|
|
2018
Q1 | $315K | Buy |
7,841
+4,431
| +130% | +$186K | ﹤0.01% | 5118 |
|
|
2017
Q4 | $119K | Buy |
3,410
+1,658
| +95% | +$48.3K | ﹤0.01% | 5671 |
|
|
2017
Q3 | $38K | Buy |
1,752
+1,562
| +822% | +$31.4K | ﹤0.01% | 6048 |
|
|
2017
Q2 | $3K | Sell |
190
-1,116
| -85% | -$24.1K | ﹤0.01% | 6690 |
|
|
2017
Q1 | $36K | Buy |
1,306
+289
| +28% | +$8.07K | ﹤0.01% | 6075 |
|
|
2016
Q4 | $27K | Buy |
1,017
+710
| +231% | +$23.1K | ﹤0.01% | 6215 |
|
|
2016
Q3 | $10K | Buy |
307
+67
| +28% | +$1.58K | ﹤0.01% | 6396 |
|
|
2016
Q2 | $5K | Sell |
240
-799
| -77% | -$12.4K | ﹤0.01% | 6683 |
|
|
2016
Q1 | $14K | Buy |
+1,039
| New | +$14.5K | ﹤0.01% | 6280 |
|
Other funds holding WVE
RCM
GP
MC
DCM
6CM
Bank of America's WVE Position: Q1 2026 in Review
Bank of America increased its Wave Life Sciences (WVE) stake by 29% in Q1 2026, buying an estimated $702K and bringing the position to 236,760 shares worth $1.72M. The position accounts for ﹤0.01% of the portfolio, ranked #4213.
Bank of America first reported a position in WVE in Q1 2016 and has held it in 41 quarters since. The position peaked at $5.39M in Q4 2024. 230 funds tracked by Wall St. Rank hold WVE as of Q1 2026.
- Bank of America held 236,760 shares of Wave Life Sciences worth $1.72M as of Q1 2026.
- Bank of America bought 53,905 Wave Life Sciences shares in Q1 2026, an estimated $702K.
- Wave Life Sciences made up ﹤0.01% of Bank of America's portfolio in Q1 2026, its #4213 holding.
- Bank of America first reported a position in Wave Life Sciences in Q1 2016 and has held it in 41 quarters since.
- Bank of America's Wave Life Sciences position peaked at $5.39M in Q4 2024.
- 230 funds tracked by Wall St. Rank held Wave Life Sciences as of Q1 2026.
Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.